ALISON PETERSON: Open Payments
NPI 1225661952 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,786 in 120 payments from 19 companies in 2025. Trend: 2023 $3,123 · 2024 $2,798 · 2025 $2,786
Food & beverage: $2,701Education: $85
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $620 |
| ABBVIE INC. | 18 | $319 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $237 |
| Arcutis Biotherapeutics, Inc. | 12 | $209 |
| Organon LLC | 5 | $191 |
| GENZYME CORPORATION | 2 | $182 |
| Lilly USA, LLC | 3 | $167 |
| Galderma Laboratories, L.P. | 21 | $136 |
| LEO Pharma Inc. | 6 | $123 |
| Incyte Corporation | 6 | $119 |
Products named: Zoryve, COSENTYX, SKYRIZI, EBGLYSS, Rhapsido, VTAMA, DUPIXENT, NEMLUVIO.
Industry payments across AL — which companies pay providers there.
